Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.

By H. Mao, K. Roy, V. L. Troung-Le, Kevin A. Janes, K. Lin, Y. Wang, J. August, K. Leong. Journal of Controlled Release, 2001

1,198 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Perspectives for nano-biotechnology enabled protection and nutrition of plants. (2011, background): “Biocompatibility, low immunogenicity and minimal cytotoxicity render chitosan NPs (100–250 nm) a good alternative to viral or lipid mediated transfection (Mao et al., 2001).”
Nanoparticles as drug delivery systems (2012, background): “, albumin [94], DNA [93], chitosan [93, 128] gelatin [131].”
Stability of Chitosan—A Challenge for Pharmaceutical and Biomedical Applications (2015, background): “The dried particles were found not to aggregate and to be easily re-suspended in both saline and PBS, upon one-month storage at either 4 °C or −20 °C [95].”
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway (2002, background): “These coacervates had a transfection activity similar to ligand-targeted gelatin nanoparticles with chloroquine, but transfection of coacervates was not improved either by Tf or by chloroquine (Mao et al., 2001).”